Asset

  • No.

    10

  • Asset Title

    Small Molecule Aryl Hydrocarbon Receptor Agonists for Ulcerative Colitis and Skin Inflammatory Diseases

  • Organization

    Stanford SPARK Program

  • Product Type

    Small molecule

  • Therapeutic Area

    Dermatology, Gastroenterology

  • Development Stage

    Hit To Lead or Lead Optimization

  • Technical Summary

    -

  • Researcher

    Matthew Davidson, Julie Saiki

  • Patent

    US 11154533 B2 (2021.10.26)
    Patent Family: KR, US, EP, JP, CN, CA, AU, TW

  • Publication

    Saiki JP, Andreasson JO, Grimes KV, Frumkin LR, Sanjines E, Davidson MG, Park KT, Limketkai B. Treatment-refractory ulcerative colitis responsive to indigo naturalis. BMJ Open Gastroenterol. 2021 Dec;8(1):e000813. doi: 10.1136/bmjgast-2021-000813.

  • Attachment

    Stanford_One-pager_Aryl hydrocarbon receptor (AhR) agonists for autoimmune and inflammatory diseases (Azora).pdf

TOP